CQDM - Nouvelles

ABOUT
PROGRAMS
FUNDED PROJECTS
NEWS
Contact
FR
SPECIAL INITIATIVES

ABOUT
PROGRAMS
FUNDED PROJECTS
NEWS
Contact
FR
SPECIAL INITIATIVES

Our Latest News

CQDM is proud to contribute to the success of Medicago and its partners, winners of the 2020 RSRI Innovation Award from ADRIQ
19 November 2020
CQDM portfolio company Mesentech secures new capital to bring lead product to clinical phase
11 November 2020
CQDM funds the development of a novel artificial intelligence tool for cardiovascular clinical trials
5 November 2020
Philip Tagari Appointed to CQDM’s Board of Directors
5 October 2020
CQDM Awards a Grant to Centre de Recherche du CHU de Québec-Université Laval …
20 July 2020
nplex-McGill partnership selected by CQDM for a $1M grant to apply next-generation ELISA in drug discovery
16 July 2020
CQDM announces funding to develop a test to predict disease progression in patients infected with COVID-19
14 July 2020
We are hiring! Director – Scientific Affairs – Apply now!
30 June 2020
CQDM becomes a shareholder of Mesentech to support the validation of a highly promising bone-targeting drug delivery technology
22 June 2020
Health Innovation: Investing Now to Face the Crises of Tomorrow
20 June 2020
The Canadian Cancer Society, the Quebec Breast Cancer Foundation and CQDM join forces to fight breast cancer
18 June 2020
CQDM grants $1.15 M in funding to Professor Yves St-Pierre’s team to develop a revolutionary immunotherapy against breast cancer
18 June 2020
New call for proposals under the Fonds d’accélération des collaborations en santé
16 June 2020
Mobilisation sans précédent de l’écosystème québécois de recherche et d’innovation contre la COVID-19
19 May 2020
Theratechnologies Unveils New Positive Data For Its Investigational Peptide-Drug Conjugates Targeting Sortilin Positive Cancers
15 May 2020
Collaborative project of more than $1.2 million using artificial intelligence to optimize the production of vaccines, announced by CQDM and Medicago R&D
5 May 2020
Pre-launch of a new call for proposals in June 2020: discover the latest updates!
27 April 2020
Private: COVID-19 : CQDM to launch a call for solutions against COVID-19
17 March 2020
CQDM welcomes Zymeworks as a new member of CQDM’s biopharmaceutical consortium
27 February 2020
CQDM partners with GlycoNet to support innovative Glycomics research in Canada
25 February 2020
2nd Annual Gordon Shore Prize – Postdoctoral Internships in the Biopharmaceutical Industry
17 February 2020
We are recruiting! Interested in a Controller – finance & administration position? Apply now!
23 January 2020
Project funded through CQDM will explore potential of Fusion Genomics’ ONETest™ to improve diagnosis of respiratory tract infections
9 January 2020
Postponed deadline to submit a SynergiQc project
1 January 2020
CQDM and the Canadian Cancer Society commend Theratechnologies and UQAM for their success in developing a new therapy against the most aggressive form of breast cancer
18 December 2019
2nd Annual Gordon Shore Prize – Call for Proposal to Private Companies
2 December 2019
Bernard Massie and Cameron Black appointed to CQDM’s Scientific Advisory Board
29 November 2019
The project led by Michel Bouvier and Domain Therapeutics with the support of CQDM is awarded the RSRI Recognition Award at the ADRIQ Innovation Prize Gala
22 November 2019
Zealand Pharma’s acquisition of Encycle Therapeutics highlights the impact of CQDM’s early support
11 November 2019
We are RECRUITING ! Interested in an Administrative Coordinator position ? Apply now !
8 November 2019
CQDM, the CCS and Theratechnologies grant $1.7M to UQAM in breast cancer research
4 October 2019
New appointments to CQDM’s Board of Directors and Scientific Advisory Board
23 September 2019
PARTENAR-IA – * New * Grants for IA research projects applied to the biopharmaceutical sector
20 August 2019
We are RECRUITING ! Interested in a Senior Director, Business Development position ? Apply now !
19 July 2019
SynergiQc-International: New funding opportunity for public-private biopharmaceutical research
16 July 2019
Amgen and Takeda join the Quantum Leap project led by CQDM and Feldan Therapeutics
4 June 2019
Contribution from the MEI ($3.3M) allows CQDM to support 5 biopharmaceutical research projects ($15.5M)
4 June 2019
The CCS, CQDM and biotech companies will invest nearly $10M to support 3 breast cancer research projects
1 June 2019
CQDM, Diazon and the Oncopole in collaboration with Mitacs announce the two laureates of the 2019 Gordon Shore Prize
23 May 2019
Hope on the horizon for hard-to-treat breast cancers
14 May 2019
CQDM, HBHL, Corbin Therapeutics and Brain Canada award $1.5 M to McGill Prof. Philippe Gros
2 May 2019
We are RECRUITING! Interested in a Project Coordinator position? Apply now!
29 April 2019
We are RECRUITING! Interested in a Artificial Intelligence Project Manager position? Apply now!
26 April 2019
IMV and CRCHU de Québec-U Laval Collaboration Awarded a CQDM Grant to Develop First-in-class Dual Target T cell Therapy in Bladder Cancer Based on IMV’s DPX Technology
18 March 2019
Call for Applications for the Gordon Shore Prize – Internships for new graduates
21 February 2019
Philippe Walker appointed Member of the Scientific Advisory Board of CQDM
29 January 2019
Call for Proposal to Private Companies – Post-Diploma Internships Co-Funded through the Gordon Shore Prize
9 January 2019
Merck Canada reaffirms its commitment to CQDM with a $3.5M contribution to sustain innovation in Life Sciences
19 November 2018
Pfizer Canada renews its support to CQDM with a $550,000 contribution
19 November 2018
Amgen becomes a new member of CQDM to further the development of cutting-edge drug discovery
19 November 2018

Annual Archive

2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008

About CQDM

Our Mission, Vision and Impact
Structure & Governance
Team
Members
Collaborators
Contact us

Programs

Quantum Leap
SynergiQc
PARTENAR-IA | ENTREPRISE
PARTENAR-IA | ACADÉMIQUE
FACS – Fonds d’accélération des collaborations en santé
SynergiQc-International
Mentorship
Completed Programs

Follow Us!

Tweets by @CQDM_Canada

© CQDM 2020 // Web: Draxo Marketing

Nous utilisons des témoins (cookies) et d'autres technologies de suivi pour améliorer votre expérience de navigation sur notre site Web. En naviguant sur notre site Web, vous consentez à ce que nous utilisions des témoins (cookies) et d'autres technologies de suivi. Accepter

Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.